Home

Nath Bio-genes (india) Ltd PE Ratio

Image

Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN

PE

9

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Nath Bio-Genes (India) Ltd is 9 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 8.3 on March 2024 . This represents a CAGR of 3.82% over 2 years.
  • The Latest Trading Price of Nath Bio-Genes (India) Ltd is ₹ 176 as of 15 Jan 15:30 .
  • The PE Ratio of Miscellaneous Industry has changed from 122.9 to 64.1 in 5 years. This represents a CAGR of -12.21%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Miscellaneous industry is 64.1. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Nath Bio-Genes (India) Ltd

No data available

Company Fundamentals for Nath Bio-Genes (India) Ltd

Image

Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN

Share Price

₹ 176

-1.50 (-0.85%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Nath Bio-Genes (India) Ltd

1M

1Y

3Y

5Y

Monitoring Nath Bio-Genes (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025177.5
13 Jan 2025170.45
10 Jan 2025173.25
09 Jan 2025180.15
08 Jan 2025180.05
07 Jan 2025184.4
06 Jan 2025182.55
03 Jan 2025190.3
02 Jan 2025188.3
01 Jan 2025189.05

SWOT Analysis Of Nath Bio-Genes (India) Ltd

Strength

3

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Nath Bio-Genes (India) Ltd

Asset Value vs Market Value of Nath Bio-Genes (India) Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Nath Bio-Genes (India) Ltd337.32
GMR Airports Ltd76489
International Gemmological Institute (India) Ltd23710
Sagility India Ltd22709
Godrej Agrovet Ltd13752

PE Ratio of Nath Bio-Genes (India) Ltd Explained

``

337.32

Market cap

40

Earnings

9.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Miscellaneous Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Nath Bio-Genes (India) Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Nath Bio-Genes (India) Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Nath Bio-Genes (India) Ltd

No data available

* All values are in %

About Nath Bio-Genes (India) Ltd

  • Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
  • The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

Nath Bio-Genes (India) Ltd News Hub

Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter

Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024

Read more

2024-08-07 00:00:00

Nath Bio-Genes (India) announces board meeting date

Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 October 20

Read more

2024-10-17 00:00:00

Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter

Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended September 202

Read more

2024-10-23 00:00:00

Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter

Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended September

Read more

2024-10-23 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Nath Bio-Genes (India) Ltd

What is the current PE Ratio of Nath Bio-Genes (India) Ltd?

The Current PE Ratio of Nath Bio-Genes (India) Ltd is 9.0 as on 15 Jan 2025.

What is the average PE Ratio of the Miscellaneous industry?

The average industry PE Ratio of Miscellaneous is 64.1 as on 15 Jan 2025.

What was the PE Ratio of Nath Bio-Genes (India) Ltd last year?

The PE Ratio of Nath Bio-Genes (India) Ltd was 7.69 last year, now the PE ratio is 9.0, showing a year-on-year growth of 17.0%.

What does the PE Ratio of Nath Bio-Genes (India) Ltd indicate about its stock?

The PE Ratio of Nath Bio-Genes (India) Ltd is 9.0. This ratio indicates that investors are willing to pay 9.0 times the earnings per share for each share of Nath Bio-Genes (India) Ltd.

What is the PE Ratio Growth of Nath Bio-Genes (India) Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Nath Bio-Genes (India) Ltd grew by 17.0% whereas, the EPS ratio grew by -97.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions